Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynne M Bird

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Neurology|January 14, 2021
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman SyndromeLynne M Bird, Cesar Ochoa-Lubinoff, Wen-Hann Tan, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2022
The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi SyndromeJennifer L Miller, André Lacroix, Lynne M Bird, et al.
Communications Biology|December 15, 2022
Neural complexity is a common denominator of human consciousness across diverse regimes of cortical dynamicsJoel Frohlich, Jeffrey N Chiang, Pedro A M Mediano, et al.
Journal of Neurodevelopmental Disorders|June 15, 2024
Developmental milestones and daily living skills in individuals with Angelman syndromeAnjali Sadhwani, Sonya Powers, Anne Wheeler, et al.
American Journal of Medical Genetics. Part A|April 4, 2019
Maladaptive behaviors in individuals with Angelman syndromeAnjali Sadhwani, Jennifer M Willen, Nicole LaVallee, et al.
Neurogenetics|October 2, 2007
Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain diseaseUte Hehr, Goekhan Uyanik, Claudia Gross, et al.
American Journal of Medical Genetics. Part A|November 15, 2014
Truncating mutations in the last exon of NOTCH3 cause lateral meningocele syndromeKaren W Gripp, Katherine M Robbins, Nara L Sobreira, et al.
Human Mutation|March 30, 2021
Haploinsufficiency of POU4F1 causes an ataxia syndrome with hypotonia and intention tremorBryn D Webb, Anthony Evans, Thomas P Naidich, et al.
American Journal of Medical Genetics. Part A|December 16, 2024
Community-Sourced Reporting of Mortalities in Angelman Syndrome (1979-2022)Adriana T Gomes, Amanda Moore, Meagan Cross, et al.
Brain Communications|May 25, 2022
Longitudinal EEG model detects antisense oligonucleotide treatment effect and increased UBE3A in Angelman syndromeElizabeth R Spencer, Wen Shi, Robert W Komorowski, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Neurology|January 14, 2021
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman SyndromeLynne M Bird, Cesar Ochoa-Lubinoff, Wen-Hann Tan, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2022
The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi SyndromeJennifer L Miller, André Lacroix, Lynne M Bird, et al.
Communications Biology|December 15, 2022
Neural complexity is a common denominator of human consciousness across diverse regimes of cortical dynamicsJoel Frohlich, Jeffrey N Chiang, Pedro A M Mediano, et al.
Journal of Neurodevelopmental Disorders|June 15, 2024
Developmental milestones and daily living skills in individuals with Angelman syndromeAnjali Sadhwani, Sonya Powers, Anne Wheeler, et al.
American Journal of Medical Genetics. Part A|April 4, 2019
Maladaptive behaviors in individuals with Angelman syndromeAnjali Sadhwani, Jennifer M Willen, Nicole LaVallee, et al.
Neurogenetics|October 2, 2007
Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain diseaseUte Hehr, Goekhan Uyanik, Claudia Gross, et al.
American Journal of Medical Genetics. Part A|November 15, 2014
Truncating mutations in the last exon of NOTCH3 cause lateral meningocele syndromeKaren W Gripp, Katherine M Robbins, Nara L Sobreira, et al.
Human Mutation|March 30, 2021
Haploinsufficiency of POU4F1 causes an ataxia syndrome with hypotonia and intention tremorBryn D Webb, Anthony Evans, Thomas P Naidich, et al.
American Journal of Medical Genetics. Part A|December 16, 2024
Community-Sourced Reporting of Mortalities in Angelman Syndrome (1979-2022)Adriana T Gomes, Amanda Moore, Meagan Cross, et al.
Brain Communications|May 25, 2022
Longitudinal EEG model detects antisense oligonucleotide treatment effect and increased UBE3A in Angelman syndromeElizabeth R Spencer, Wen Shi, Robert W Komorowski, et al.
Pageof 12